Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: St. Petersburg FL, Tampa FL, Fort Myers FL,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
for
Metabolic Dysfunction Associated Steatohepatitis
Location: St. Petersburg FL, Bradenton FL, Riverview FL, Tampa FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632457
Phase 3, Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Location: St. Petersburg FL, Clearwater FL, Bradenton FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632444
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: St. Petersburg FL, Clearwater FL, Tampa FL,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase 3, Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
for
Overweight or Obesity
Location: St. Petersburg FL, Inverness FL, The Villages FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07685808
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: St. Petersburg FL, Tampa FL, Sarasota FL, Mobile AL,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07166094
Phase 3, Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: St. Petersburg FL, New Port Richey FL, Brooksville FL,
Location: St. Petersburg FL, Brandon FL, Kissimmee FL,
Sponsor: Trevi Therapeutics
Sex: All
Age: 40+
Code: NCT07671911
Phase 3, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: St. Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase 3, Recruiting
E-STIM Trial: Comparing the Efficacy of the Empi Select TENS to a Control for the Treatment of Chronic Lower Back Pain
for
Lower Back Pain
Location: St. Petersburg FL, Pensacola FL, Atlanta GA, Reston VA,
Sponsor: Empi, A DJO Company
Sex: All
Age: 18 - 65
Code: NCT00709748
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: St. Petersburg FL, Clearwater FL, Port Orange FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase 3, Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: St. Petersburg FL, Gainesville FL, Fort Lauderdale FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
for
Diabetic Macular Edema
Location: St. Petersburg FL, Germantown TN, Lynchburg VA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07425522
Phase 1, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: St. Petersburg FL, Pinellas Park FL, Tampa FL,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: St. Petersburg FL, Fort Lauderdale FL, Charleston SC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: St. Petersburg FL, Fort Lauderdale FL, Charleston SC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Location: St. Petersburg FL, Hudson FL, Tampa FL, Orlando FL,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: St. Petersburg FL, Pinellas Park FL, Tampa FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT06541704
Phase 3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: St. Petersburg FL, Tampa FL, Fort Myers FL,